Add to ORKGstudy protocol of an international randomised trolled study on the with either methylphenidate (20 to 40 mg/day) or placebo for 2.5 days, given once or twice daily. The main Kluge et al. BMC Psychiatry 2013, 13:7
OBJECTIVE: In the last decades, several cognitive-enhancing drugs have been sold onto the drug marke...
The effects of methylphenidate (MPH) on 32 healthy human male volunteers (aged 18 to 25 years, mean ...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
BACKGROUND: Treatment of patients with acute mania remains a considerable medical challenge since on...
Background: Treatment of patients with acute mania remains a considerable medical challenge since on...
Based on many clinical and preclinical findings the 'vigilance regulation model of mania' postulates...
Aims To assess the efficacy of methylphenidate as a substitution therapy for amphetamine/methampheta...
This is a 4 week, randomized, double-blind, placebo-controlled study to examine the effects of methy...
Methylphenidate is primarily used for attention deficit hyperactivity disorder (ADHD) in children. T...
Objective. Attention-deficit hyperactivity disorder (ADHD) is a developmental disorder characterized...
Purpose: In advanced cancer, the prevalence of fatigue is high and can be related to treatment or di...
Acetylcholinesterase inhibitors (Acel) and memantine might prove useful in bipolar disorder (BD) giv...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
We review preclinical and clinical evidences strongly suggesting that memantine, an old drug current...
International audiencePurpose: The aim of this study was to describe the extent of ă methylphenidate...
OBJECTIVE: In the last decades, several cognitive-enhancing drugs have been sold onto the drug marke...
The effects of methylphenidate (MPH) on 32 healthy human male volunteers (aged 18 to 25 years, mean ...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
BACKGROUND: Treatment of patients with acute mania remains a considerable medical challenge since on...
Background: Treatment of patients with acute mania remains a considerable medical challenge since on...
Based on many clinical and preclinical findings the 'vigilance regulation model of mania' postulates...
Aims To assess the efficacy of methylphenidate as a substitution therapy for amphetamine/methampheta...
This is a 4 week, randomized, double-blind, placebo-controlled study to examine the effects of methy...
Methylphenidate is primarily used for attention deficit hyperactivity disorder (ADHD) in children. T...
Objective. Attention-deficit hyperactivity disorder (ADHD) is a developmental disorder characterized...
Purpose: In advanced cancer, the prevalence of fatigue is high and can be related to treatment or di...
Acetylcholinesterase inhibitors (Acel) and memantine might prove useful in bipolar disorder (BD) giv...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
We review preclinical and clinical evidences strongly suggesting that memantine, an old drug current...
International audiencePurpose: The aim of this study was to describe the extent of ă methylphenidate...
OBJECTIVE: In the last decades, several cognitive-enhancing drugs have been sold onto the drug marke...
The effects of methylphenidate (MPH) on 32 healthy human male volunteers (aged 18 to 25 years, mean ...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...